Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effects of nifedipine and hydralazine induced hypotension on sympathetic activity.

Literature DB >> 7160415

The effects of nifedipine and hydralazine induced hypotension on sympathetic activity.

M B Murphy, A J Scriven, M J Brown, R Causon, C T Dollery.

Abstract

To determine whether inhibition of sympathetic activity is a factor in calcium antagonist induced hypotension, plasma noradrenaline was measured after intravenous infusion of hydralazine (25 mg) and the calcium antagonist nifedipine (4 mg) in 6 hypertensive males. The resultant reduction in mean blood pressure (12.4% and 14.2% respectively) was accompanied by similar increases in heart rate and plasma noradrenaline concentration. These results suggest that calcium slow channel blockade does not inhibit noradrenaline release from sympathetic nerves and that nifedipine induced hypotension is independent of such a mechanism.

Entities: Chemical Disease

Mesh：

Substances：

Year: 1982 PMID： 7160415 DOI： 10.1007/bf00637492

Source DB: PubMed Journal: Eur J Clin Pharmacol ISSN： 0031-6970 Impact factor: 2.953

14 in total

1. [Noradrenalin loss from the isolated rabbit heart following sympathetic nerve irritation and its pharmacological alteration].

Authors: S HUKOVIC; E MUSCHOLL
Journal: Naunyn Schmiedebergs Arch Exp Pathol Pharmakol Date: 1962

Review 2. Vasodilator drugs in the treatment of hypertension.

Authors: J Koch-Weser
Journal: Arch Intern Med Date: 1974-06

3. Acute and chronic effects of nifedipine in arterial hypertension.

Authors: O L Pedersen; E Mikkelsen
Journal: Eur J Clin Pharmacol Date: 1978-12-18 Impact factor: 2.953

4. [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].

Authors: G Grün; A Fleckenstein
Journal: Arzneimittelforschung Date: 1972-02

5. Nifedipine, a new antihypertensive with rapid action.

Authors: M Guazzi; M T Olivari; A Polese; C Fiorentini; F Magrini; P Moruzzi
Journal: Clin Pharmacol Ther Date: 1977-11 Impact factor: 6.875

6. Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors: M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal: Circulation Date: 1979-05 Impact factor: 29.690

Review 7. Calcium, calcium-antagonistic drugs and the heart.

Authors: K Landmark; H Refsum
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1978

8. Antihypertensive effect of (4-2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (Nifedipine, Bay-a 1040), a new coronary dilator.

Authors: M Murakami; E Murakami; N Takekoshi; M Tsuchiya; T Kin
Journal: Jpn Heart J Date: 1972-03

9. Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity.

Authors: M J Brown; D A Jenner
Journal: Clin Sci (Lond) Date: 1981-11 Impact factor: 6.124

10. THE PART PLAYED BY CALCIUM IN DETERMINING THE RESPONSE TO STIMULATION OF SYMPATHETIC POSTGANGLIONIC FIBRES.

Authors: J H BURN; W R GIBBONS
Journal: Br J Pharmacol Chemother Date: 1964-06

13 in total

Review 1. Central sympathoinhibitory effects of calcium channel blockers.

Authors: F H Leenen; M Ruzicka; B S Huang
Journal: Curr Hypertens Rep Date: 2001-08 Impact factor: 5.369

Review 2. Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors: E M Sorkin; S P Clissold; R N Brogden
Journal: Drugs Date: 1985-09 Impact factor: 9.546

3. Influence of acetylator status on the haemodynamic effects and pharmacokinetics of cadralazine in healthy subjects.

Authors: P Brunel; J B Lecaillon; T T Guyene; P Imhof; J Ménard
Journal: Br J Clin Pharmacol Date: 1990-05 Impact factor: 4.335

4. Effect of captopril on changes in plasma noradrenaline induced by sodium nitroprusside.

Authors: R H Becker; A D Struthers; M J Brown
Journal: Br J Clin Pharmacol Date: 1986-10 Impact factor: 4.335

5. Topical minoxidil: cardiac effects in bald man.

Authors: F H Leenen; D L Smith; W P Unger
Journal: Br J Clin Pharmacol Date: 1988-10 Impact factor: 4.335

6. Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.

Authors: I Berlin; P Lechat; G Deray; C Landault; G Maistre; V Chermat; R Brouard; C Ressayre; A J Puech
Journal: Eur J Clin Pharmacol Date: 1993 Impact factor: 2.953